Published in Medical Letter on the CDC and FDA, May 24th, 2006
"We were notified yesterday that the agency has not yet completed their review of our application," said Edward M. Rudnic, PhD, president and CEO of Advancis. "However, we were informed that the FDA will be working to complete their review and we look forward to receiving the FDA's final action in the near future. We draw...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.